Lecture 7 - Cancer Stem Cells 2 Flashcards

1
Q

What are the two critical features of cancer progression and prognosis?

A

The ability of the tumour to grow and spread to secondary sites

These features are essential for understanding cancer development.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define angiogenesis in the context of cancer.

A

Growth of new blood vessels to provide the tumour with oxygen and nutrients

Angiogenesis is crucial for tumour survival and growth.
E.g. endothelial cells migrating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is metastasis?

A

Ability of tumour cells to break away from primary tumour, travel through the body and recolonise at a distant site

Metastasis is a key factor in cancer severity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What common feature do angiogenesis and metastasis share?

A

Both involve mobility/migration of cells

This mobility is crucial for cancer spread.

Most normal cells once formed are fairly static in regards to movement.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is Epithelial-Mesenchymal Transition (EMT)?

A

A process where epithelial cells gain migratory capabilities and can contribute to metastasis

EMT is also a well-known feature during embryogenesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What initiates the mechanism of EMT?

A

Signals from tumour stroma/microenvironment

These signals include HGF and TGF-b.

From niches around the stem cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does TGF-b activate in the context of EMT?

A

Smad complex

This activation is crucial for the EMT process.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

List some transcription factors activated during EMT.

A
  • Twist
  • Snail
  • Slug
  • ZEB-1

These factors help repress epithelial genes.

Controls EMT, so upregulated in metastatic cancer.

Activated by TBF-b?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the role of PcG in EMT?

A

Repress epithelial genes by epigenetic mechanisms

This repression is essential for the transition to a migratory phenotype.

Reversal of E- and N-cadherin driven by epigenetics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What constitutes the tumour microenvironment?

A

TME is dynamic and complex environment. Collection of cancer cells and various other cell types, including immune cells, stromal cells, endotherlial cells, and the extracellular matrix and blood vessels.

This includes various components that support tumour survival.

Tumour microenvironment as important as the cancer cells themselves, e.g. growth, metastasis, etc…

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is a hallmark of cancer regarding immune response?

A

Avoidance of immune destruction

This characteristic allows cancer cells to evade the immune system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Name some mechanisms of tumour-mediated immune evasion.

A
  • Loss of tumour antigens
  • Downregulation of MHC
  • Overexpression of immune checkpoint proteins (PD-L1)
  • Overexpression of anti-apoptotic molecules
  • Secretion of immunosuppressive molecules (TGF-b, IL-10, VEGF)
  • Switching of macrophages to M2 phenotype

These mechanisms collectively help in the evasion of immune detection.

Pro-inflammatory M1 phenotype to M2 more supportive phenotype.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Fill in the blank: The link between characteristics and processes in cancer is _______.

A

Mesenchymal Stem cells

Mesenchymal stem cells play a significant role in the tumor microenvironment.

The factors secreted and processes supported are similar.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What must therapies target in addition to the non-stem cells in tumors?

A

Therapies need to target the small population of tumour-initiating cancer cells

This is crucial for effective cancer treatment.

Therapies targeting rapidly proliferating, non-differentiated cells.

However, therapies must not affect normal stem cells as these are needed for repair and normal function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are ABC transporters and their role in stem cells?

A

APC transporters are membrane proteins that are responsible for ATP-powered translocation of substrates.

Presence of ABC transporters (P-glycoprotein) protects stem cells against foreign toxins

Expression is lost on differentiation.

Overexpression of ABC transporters to rapidly pump out toxins as a safety mechanism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What issue arises with ABC transporters in tumor cells?

A

In tumor cells, this manifests as drug resistance

This has led to the development of ABC inhibitors as adjuvant therapy - could target WT stem cells though.

17
Q

What initial compounds were toxic in the development of ABC inhibitors?

A

Verapamil, cyclosporin A

These were early compounds used but were found to be toxic.

Progress has been made with natutral products such as flavonoids and terponoids.

18
Q

What is the significance of the Wnt pathway in cancer therapy?

A

Interest in β-catenin/TCF inhibition and targeting downstream of APC/Axin

Wnt is reuired to target downstream of APC/Axin.

Inhibition of TCF induces differentiation of colorectal cancer cells.

19
Q

What causes resistance to chemotherapy and radiation in cancer cells?

A

Bmi-1 expression causes resistance due to DNA repair

Enhanced EMT occurs due to hypoxia-induction of HIF-1α/Bmi complexes.

20
Q

What is the effect of inhibiting Bmi-1 in cancer treatment?

A

Inhibition of Bmi-1 sensitizes cancer stem cells to chemotherapy and radiotherapy, activates immune responses, sensitises CSCs to anti-PD-1 therapies by recruitment of CD8+ cells.

It also activates immune responses.

21
Q

What is PTC-596 and its role in cancer treatment?

A

An orally active and selective Bmi-1 inhibitor inducing p53-independent mitochondrial apoptosis in AML progenitor cells

Also being tested in myelomas and gliomas.

22
Q

What was the outcome of adding arsenic trioxide in APL treatment?

A

Reversed resistance and eradicated tumor cells

ATRA converts PML-RAR complex from repressor to transactivator - drives expression of differentiation genes (e.g. C/EBP). Subsequently degrades TF complex)

23
Q

What are MMP inhibitors and their challenges?

A

MMP inhibitors block activity of matrix metalloproteinases (MMPs) whcih are enzymes responsible for degrading the ECM)

MMP inhibitors (e.g., Marimastat) face lack of efficacy and toxicity due to lack of specificity

Ongoing studies aim to develop antibodies to membrane-bound MMPs.

24
Q

What is the role of pharmacological targeting of netrin-1 in cancer?

A

Inhibits EMT in cancer

This presents opportunities for pharmacological intervention.

25
What are tumor-tropic Trojan horses in cancer treatment?
Using mesenchymal stem cells as cellular nanotheranostics ## Footnote MSCs can target cancer stem cells.
26
What are theranostics?
Therapeutic diagnostics (e.g., quantum dots) ## Footnote Gold particles or magnetic metal oxides can be visualized and heat up to ablate surrounding cancer tissue.
27
What insights have been gained from studying stem cells in relation to cancer?
Studying characteristics and processes in stem cells has provided insights into cancer initiation and progression ## Footnote This has implications for regenerative medicine.
28
What hypothesis is strengthened by shared characteristics and signaling pathways between cancer and stem cells?
The hypothesis that cancer arises from, or transgresses to, possessing stem cell-like properties ## Footnote Understanding these pathways provides novel targets for manipulation.
29
EMT process
1. Loss of cell-cell adhesion and polarity 2. Cytoskeletal reorganisation 3. Activation of mesenchymal genes and expression of mesenchymal markers 4. Increased migation and invasion 5. Resistance to anoikis ## Footnote 1. Cell-cell junctions isrupted and cells lose their apical0basal polarity 2. Actin filaments become more dynamic and allow the formation of cell protrusions 3. Mesenchymal genes often encodes genes involved in cell migration, invasion, ECM remodelling, such as MMPs 4. Cells may also produce MMPs that degrade the ECM, allowing them to move through the tissue 5. Anoikis is a form of cell death that occurs when cells detach from the ECM. Resistance allows them to continue to survive and migrate even when detached.
30
Mechanism of EMT
1. Initiated by signals from tumour stroma/microenvironment, e.g. HGF, TGF-b 2. Bind tyrosine kinase receptors on neighbouring tumour cells 3. Activate signaling pathways (MAPK/PI3K) 4. TGF-b activates Smad complex 5. Activate EMT TFs - Twist/Snail/Slug/ZEB-1 6. Repress epithelial genes by PcG epigenetic mechniams 7. EMT results in acquisition of migratory capabilities
31
Where is the best place for therapeutics to target?
The Wnt pathway can be targeted at multiple points, with approaches focusing on: 1. Wnt ligand secretion, e.g. PORCN 2. Receptor binding, e.g. Vantictumab 3. Downstream signaling inhibitors, e.g. inhibiting GSK-3b or targeting TCF/LEF
32
What does Bmi-1 expression cause in cancer?
* Resistance to chemotherapy and radiation due to DNA repair * Enhanced EMT due to hypoxia-induction of HIF-1a/Bmi complexes * Activation of PI3K and NFkB to promote cell growth
33
What does high dose ATRA induce in APL?
All-trans retinoic acid (ATRA) induced haematological remission byt after a while patients relapsed in APL.
34
What does addition of arsenic trioxide cause in APL?
Reversed resistance and eradicated tumour cells.
35
What does ATRA do to PML-RAR complexes?
Converts PML-RAR complexes from repressor to transactivator to drive expression of differentiation genes (e.g. C/EBP).
36
Example of C-MET inhibitor
Cabozantinib (SMI) ## Footnote C-MET is TRK so has enzymatic site that can be inhibited.
37
Ways to target EMT and metastasis
* MMP inhibitors * C-MET inhibitors * Restoration of metastatic suppressors ## Footnote Steroid inducers of transcription.
38
What are theranostics?
Approach that combines diagnostics and therapeutics using the same targeted molecule to both identify and treat disease.
39
How can a theranostic nanoparticle be enhanced?
Complexation with genes or chemotherapeutic agents.